Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyasu Ishida

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Glycobiology|August 11, 2006
Molecular cloning and characterization of a novel human beta1,3-glucosyltransferase, which is localized at the endoplasmic reticulum and glucosylates O-linked fucosylglycan on thrombospondin type 1 repeat domainTakashi Sato, Maiko Sato, Katsue Kiyohara, et al.
FEBS Letters|December 29, 2004
A novel beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancerHiroyasu Ishida, Akira Togayachi, Tokiko Sakai, et al.
Japanese Journal of Clinical Oncology|July 14, 2021
Cancer-related FGFR2 overexpression and gene amplification in Japanese patients with gastric cancerKeiko Minashi, Takeshi Yamada, Hisashi Hosaka, et al.
Gastrointestinal Endoscopy|April 22, 2018
Newly developed endoscopic detachable snare ligation therapy for colonic diverticular hemorrhage: a multicenter phase II trial (with videos)Daisuke Akutsu, Toshiaki Narasaka, Katsumasa Kobayashi, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|April 17, 2015
Phase I study of gemcitabine, cisplatin, and S-1 combination therapy for patients with untreated advanced biliary tract cancerToshikazu Moriwaki, Hiroyasu Ishida, Masahiro Araki, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2007
Polylactosamine on glycoproteins influences basal levels of lymphocyte and macrophage activationAkira Togayachi, Yuko Kozono, Hiroyasu Ishida, et al.
Medical Oncology (Northwood, London, England)|October 16, 2014
Glasgow Prognostic Score predicts poor prognosis among advanced biliary tract cancer patients with good performance statusToshikazu Moriwaki, Kazunori Ishige, Masahiro Araki, et al.
International Journal of Clinical Oncology|May 16, 2019
Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER)Toshikazu Moriwaki, Yoshinori Sakai, Hiroyasu Ishida, et al.
International Journal of Colorectal Disease|May 18, 2022
Prospective analysis of the expression status of FGFR2 and HER2 in colorectal and gastric cancer populations: DS-Screen StudyHisateru Yasui, Atsushi Takeno, Hiroki Hara, et al.
Clinical Colorectal Cancer|January 19, 2016
Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study)Tomohiro Nishina, Toshikazu Moriwaki, Mitsuo Shimada, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Glycobiology|August 11, 2006
Molecular cloning and characterization of a novel human beta1,3-glucosyltransferase, which is localized at the endoplasmic reticulum and glucosylates O-linked fucosylglycan on thrombospondin type 1 repeat domainTakashi Sato, Maiko Sato, Katsue Kiyohara, et al.
FEBS Letters|December 29, 2004
A novel beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancerHiroyasu Ishida, Akira Togayachi, Tokiko Sakai, et al.
Japanese Journal of Clinical Oncology|July 14, 2021
Cancer-related FGFR2 overexpression and gene amplification in Japanese patients with gastric cancerKeiko Minashi, Takeshi Yamada, Hisashi Hosaka, et al.
Gastrointestinal Endoscopy|April 22, 2018
Newly developed endoscopic detachable snare ligation therapy for colonic diverticular hemorrhage: a multicenter phase II trial (with videos)Daisuke Akutsu, Toshiaki Narasaka, Katsumasa Kobayashi, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|April 17, 2015
Phase I study of gemcitabine, cisplatin, and S-1 combination therapy for patients with untreated advanced biliary tract cancerToshikazu Moriwaki, Hiroyasu Ishida, Masahiro Araki, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2007
Polylactosamine on glycoproteins influences basal levels of lymphocyte and macrophage activationAkira Togayachi, Yuko Kozono, Hiroyasu Ishida, et al.
Medical Oncology (Northwood, London, England)|October 16, 2014
Glasgow Prognostic Score predicts poor prognosis among advanced biliary tract cancer patients with good performance statusToshikazu Moriwaki, Kazunori Ishige, Masahiro Araki, et al.
International Journal of Clinical Oncology|May 16, 2019
Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER)Toshikazu Moriwaki, Yoshinori Sakai, Hiroyasu Ishida, et al.
International Journal of Colorectal Disease|May 18, 2022
Prospective analysis of the expression status of FGFR2 and HER2 in colorectal and gastric cancer populations: DS-Screen StudyHisateru Yasui, Atsushi Takeno, Hiroki Hara, et al.
Clinical Colorectal Cancer|January 19, 2016
Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study)Tomohiro Nishina, Toshikazu Moriwaki, Mitsuo Shimada, et al.
Pageof 3